106 related articles for article (PubMed ID: 9881578)
21. Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.
Pinna A; Wardas J; Cozzolino A; Morelli M
Neuropsychopharmacology; 1999 Jan; 20(1):44-51. PubMed ID: 9885784
[TBL] [Abstract][Full Text] [Related]
22. Interactions between environmental stimulation and antipsychotic drug effects on forebrain c-fos activation.
Murphy CA; Feldon J
Neuroscience; 2001; 104(3):717-30. PubMed ID: 11440804
[TBL] [Abstract][Full Text] [Related]
23. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Kuroki T; Dai J; Meltzer HY
Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
[TBL] [Abstract][Full Text] [Related]
24. The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of alpha 1-adrenergic or 5HT2 receptor blockade to haloperidol.
Fink-Jensen A; Ludvigsen TS; Korsgaard N
Neurosci Lett; 1995 Jul; 194(1-2):77-80. PubMed ID: 7478218
[TBL] [Abstract][Full Text] [Related]
25. Atypical antipsychotic properties of AD-6048, a primary metabolite of blonanserin.
Tatara A; Shimizu S; Masui A; Tamura M; Minamimoto S; Mizuguchi Y; Ochiai M; Mizobe Y; Ohno Y
Pharmacol Biochem Behav; 2015 Nov; 138():14-9. PubMed ID: 26363311
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study.
Semba J; Sakai M; Miyoshi R; Mataga N; Fukamauchi F; Kito S
Neurochem Int; 1996 Oct; 29(4):435-42. PubMed ID: 8939453
[TBL] [Abstract][Full Text] [Related]
27. Chronic administration of haloperidol and clozapine induces differential effects on the expression of Arc and c-Fos in rat brain.
Collins CM; Wood MD; Elliott JM
J Psychopharmacol; 2014 Oct; 28(10):947-54. PubMed ID: 24989643
[TBL] [Abstract][Full Text] [Related]
28. Effect of the novel sigma1 receptor ligand and putative atypical antipsychotic E-5842 on BDNF mRNA expression in the rat brain.
Ovalle S; Andreu F; Pérez MP; Zamanillo D; Guitart X
Neuroreport; 2002 Dec; 13(17):2345-8. PubMed ID: 12488824
[TBL] [Abstract][Full Text] [Related]
29. Decrease of adenylyl cyclase activity and expression by a sigma1 receptor ligand and putative atypical antipsychotic.
Monroy X; Romero G; Pérez MP; Farré AJ; Guitart X
Neuroreport; 2001 Jul; 12(9):1989-92. PubMed ID: 11435935
[TBL] [Abstract][Full Text] [Related]
30. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.
Merchant KM; Figur LM; Evans DL
Cereb Cortex; 1996; 6(4):561-70. PubMed ID: 8670682
[TBL] [Abstract][Full Text] [Related]
31. Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain.
Ishibashi T; Tagashira R; Nakamura M; Noguchi H; Ohno Y
Pharmacol Biochem Behav; 1999 Aug; 63(4):535-41. PubMed ID: 10462181
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: contrasting targets of haloperidol and clozapine.
Guo N; Vincent SR; Fibiger HC
Neuropsychopharmacology; 1998 Aug; 19(2):133-45. PubMed ID: 9629567
[TBL] [Abstract][Full Text] [Related]
33. Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus.
Ma J; Ye N; Lange N; Cohen BM
Neuroscience; 2003; 121(4):991-8. PubMed ID: 14580949
[TBL] [Abstract][Full Text] [Related]
34. Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite.
Young CD; Meltzer HY; Deutch AY
Neuropsychopharmacology; 1998 Jul; 19(1):99-103. PubMed ID: 9608582
[TBL] [Abstract][Full Text] [Related]
35. Effects of YM-43611, a novel dopamine D2-like receptor antagonist, on immediate early gene expression in the rat forebrain.
Kurokawa K; Narita M; Koshiya K; Hidaka K; Ohmori J; Satoh K
Neuropsychopharmacology; 1997 Jul; 17(1):27-33. PubMed ID: 9194047
[TBL] [Abstract][Full Text] [Related]
36. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs.
Atkins JB; Chlan-Fourney J; Nye HE; Hiroi N; Carlezon WA; Nestler EJ
Synapse; 1999 Aug; 33(2):118-28. PubMed ID: 10400890
[TBL] [Abstract][Full Text] [Related]
37. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
[TBL] [Abstract][Full Text] [Related]
39. Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs.
Cohen BM; Cherkerzian S; Ma J; Ye N; Wager C; Lange N
Psychopharmacology (Berl); 2003 Jun; 167(4):403-10. PubMed ID: 12709776
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiological effects of E-5842, a sigma1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons.
Sánchez-Arroyos R; Guitart X
Eur J Pharmacol; 1999 Jul; 378(1):31-7. PubMed ID: 10478562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
